3/22/2021
ImmunogenX and Mayo Clinic Successfully Complete the CeliacShield Trial
The Celiac Disease Foundation is proud to have been involved by recruiting patients essential for this trial’s success.
Continue ReadingResearch News
3/9/2021
Assessment of KAN-101 in Celiac Disease (ACeD) Study Open
The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue Reading3/8/2021
CEO Marilyn Geller to Present at NIAID Accelerating Progress in Celiac Disease Workshop
We are pleased to share that CEO Marilyn Geller will be presenting as the Patient Advocate at the March 18-19 National Institute of Allergy and Infectious Diseases Accelerating Progress in Celiac Disease Workshop. We encourage you to register to attend this seminal virtual meeting.
Continue Reading1/28/2021
Senate Releases FY2021 Language Directing NIH to Study Celiac Disease
The Senate Appropriations Committee has released their FY2021 funding recommendations, which includes report language directing NIH to support celiac disease research.
Continue Reading12/22/2020
Society for the Study of Celiac Disease Releases Statement on COVID-19 Vaccination
The Society for the Study of Celiac Disease (SSCD) has released a statement on the COVID-19 vaccination and its safety for celiac disease patients.
Continue ReadingRecent Posts
- The 2024 Nobel Prize in Chemistry goes to a leading celiac disease researcher
- Biomarkers May Help Predict Celiac Disease in Patients with Type 1 Diabetes
- New Wheat Discovery Could Reduce the Impact of Celiac Disease
- Adriana Carrieri's Rising Villus Award for Celiac College Research
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Research News
- Research Press
- Trending Topics
Marilyn's Message
9/26/2024
Read more2024 International Celiac Disease Symposium Recap
Last month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...